After discussion with our medical indemnity clients, we want to clarify when our Medical Indemnity policies provide cover for administering naloxone as an emergency medical treatment to reverse the life-threatening effects of a known or suspected opiate (narcotic) overdose.
VMIA’s Medical Indemnity policies provide indemnity for naloxone administration (intramuscular injection and/or nasal spray) to a patient or person by anyone acting on behalf of an organisation insured through VMIA. This includes clinical workers, non-clinical workers, and volunteers.
VMIA advises anyone administering Naloxone should follow the guidance from the Commonwealth Department of Health and Aged Care(opens in a new window).
Should you have any further queries, please do not hesitate to contact your Risk Adviser directly or our Client Advisory Team on 9270 6900 or email contact@vmia.vic.gov.au.
Updated